Cost-effectiveness of routine screening for critical congenital heart disease in US newborns
- PMID: 23918890
- PMCID: PMC4470475
- DOI: 10.1542/peds.2013-0332
Cost-effectiveness of routine screening for critical congenital heart disease in US newborns
Abstract
Objectives: Clinical evidence indicates newborn critical congenital heart disease (CCHD) screening through pulse oximetry is lifesaving. In 2011, CCHD was added to the US Recommended Uniform Screening Panel for newborns. Several states have implemented or are considering screening mandates. This study aimed to estimate the cost-effectiveness of routine screening among US newborns unsuspected of having CCHD.
Methods: We developed a cohort model with a time horizon of infancy to estimate the inpatient medical costs and health benefits of CCHD screening. Model inputs were derived from new estimates of hospital screening costs and inpatient care for infants with late-detected CCHD, defined as no diagnosis at the birth hospital. We estimated the number of newborns with CCHD detected at birth hospitals and life-years saved with routine screening compared with no screening.
Results: Screening was estimated to incur an additional cost of $6.28 per newborn, with incremental costs of $20 862 per newborn with CCHD detected at birth hospitals and $40 385 per life-year gained (2011 US dollars). We estimated 1189 more newborns with CCHD would be identified at birth hospitals and 20 infant deaths averted annually with screening. Another 1975 false-positive results not associated with CCHD were estimated to occur, although these results had a minimal impact on total estimated costs.
Conclusions: This study provides the first US cost-effectiveness analysis of CCHD screening in the United States could be reasonably cost-effective. We anticipate data from states that have recently approved or initiated CCHD screening will become available over the next few years to refine these projections.
Keywords: congenital heart defects; costs and cost analysis; neonatal screening.
Figures
Similar articles
-
A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.Public Health Rep. 2014 Jan-Feb;129(1):86-93. doi: 10.1177/003335491412900113. Public Health Rep. 2014. PMID: 24381364 Free PMC article.
-
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?Birth Defects Res A Clin Mol Teratol. 2013 Oct;97(10):664-72. doi: 10.1002/bdra.23165. Epub 2013 Sep 2. Birth Defects Res A Clin Mol Teratol. 2013. PMID: 24000201 Free PMC article.
-
Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China.Medicine (Baltimore). 2017 Nov;96(46):e8683. doi: 10.1097/MD.0000000000008683. Medicine (Baltimore). 2017. PMID: 29145300 Free PMC article.
-
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. doi: 10.3310/hta9440. Health Technol Assess. 2005. PMID: 16297355 Review.
-
Screening for critical congenital heart disease: advancing detection in the newborn.Curr Opin Pediatr. 2012 Oct;24(5):603-8. doi: 10.1097/MOP.0b013e328357a843. Curr Opin Pediatr. 2012. PMID: 22935755 Review.
Cited by
-
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591. Health Technol Assess. 2024. PMID: 38938110 Free PMC article.
-
Continuous Electroencephalogram (cEEG) Findings and Neurodevelopmental Outcomes in Neonates with Congenital Heart Disease (CHD) at 12-24 Months of Age.J Autism Dev Disord. 2024 May 31. doi: 10.1007/s10803-024-06418-y. Online ahead of print. J Autism Dev Disord. 2024. PMID: 38819704
-
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning.Cost Eff Resour Alloc. 2024 May 22;22(1):44. doi: 10.1186/s12962-024-00550-3. Cost Eff Resour Alloc. 2024. PMID: 38773527 Free PMC article.
-
Current Postlaunch Implementation of State Mandates of Newborn Screening for Critical Congenital Heart Disease by Pulse Oximetry in U.S. States and Hospitals.Am J Perinatol. 2024 May;41(S 01):e550-e562. doi: 10.1055/s-0042-1756327. Epub 2022 Dec 29. Am J Perinatol. 2024. PMID: 36580978 Free PMC article.
-
Population-based screening of newborns: Findings from the newborn screening expansion study (part two).Front Genet. 2022 Sep 1;13:867354. doi: 10.3389/fgene.2022.867354. eCollection 2022. Front Genet. 2022. PMID: 36118861 Free PMC article. Review.
References
-
- Mahle WT, Martin GR, Beekman RH, III, Morrow WR Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2012;129(1):190–192. - PubMed
-
- Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Pediatrics. 2009;124(2):823–836. - PubMed
-
- Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med. 2008;162 (10):969–974. - PubMed
-
- State of California, Department of Public Health, Birth Records. [Accessed May 18, 2012];Birth Statistical Data Tables: Table 2-1: Number of live births by age of mother, California, 1960–2005 (by place of residence) Available at: www.cdph.ca.gov/data/statistics/Pages/StatewideBirth-StatisticalDataTabl....
-
- Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2010. Natl Vital Stat Rep. 2011;60(2):1–25. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
